ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000229233.1	Ponatinib	Cervical squamouscell carcinoma and endocervical adenocarcinoma	0.049238037	Sensitive
ENSG00000229233.1	Ponatinib	Lung squamous cell carcinoma	0.036912467	Resistant